- Category Marryalyan
- DATE 25 Feb 2025
Cancer Symptom Trials and Palliative Care Clinical Studies Collaborative
February 2025

PaCCSC & CST Research Forum 2025
The Science behind the Art of care: Clinical trials in cancer symptoms and palliative care
27-28 March 2025 | ICC, Sydney
We’re excited to invite you to the PaCCSC & CST Research Forum 2025, where we’ll explore the scientific foundations that inform best practices in cancer symptom management and palliative care.
We are thrilled to welcome three international keynote speakers to the forum:
-
- Professor William Dale, Geriatric Medicine, USA
- Professor Catherine Walshe, Palliative Care, UK
- Professor Steve Pantilat, Palliative Care, USA
This event is for researchers, healthcare professionals and consumers with experience or interest in palliative care or cancer symptom management research.
We invite you to take this opportunity to connect with leading experts and build your networks in palliative care and cancer symptom management research.
Register now
Email enquiries to [email protected]
Expressions of interest – Join a PaCCSC & CST Symptom Node Subcommittee
Help shape the future of palliative care and cancer symptom management
Researchers, clinicians and consumers with an interest in palliative care and/or cancer symptom management are invited to express interest in joining a PaCCSC & CST Symptom Node Subcommittee
Our seven Symptom Node Subcommittees (SNSCs) each lead a dedicated research program focused on a specific symptom:
-
- Appetite and cachexia
- Breathlessness and sleep
- Cognitive and neurological disorders
- Fatigue
- Gut dysfunction
- Nausea
- Pain
This is an excellent opportunity to extend your personal research profile as part of a collaborative research team, while contributing to better quality-of-life outcomes for patients and families.
Hannah Wardill, Chair, Gut Dysfunction Symptom Node SubCommittee
We'd love to hear from you if:
-
- you have an interest in collaborating on a research program investigating one or more symptoms and its impacts on people with cancer or in palliative care
- have capacity to be committed and engaged to support the work of the node.
Commitment
Term of membership: two years Meeting schedule: quarterly 1-hour meetings. For questions or to express interest in joining an SNSC, please email [email protected]
IMPACCT Rapid Program
The IMPACCT Rapid Program is a collaborative international quality improvement program that studies the prospective use of medications and non-pharmacological interventions commonly used in palliative care and cancer symptom management.
Participating in the program provides an opportunity to develop the capacity and research capabilities of you and your staff who may not otherwise have the opportunity to engage in research.
Adult series
Pancreatic Enzyme Replacement Therapy (PERT) for pancreatic cancer – series 53
The PERT for pancreatic cancer Rapid series is open for recruitment. This study aims to explore clinicians’ prescribing practices and evaluate the efficacy and safety of PERT for people with pancreatic cancer. PERT is a biological medication administered in capsule form to treat pancreatic exocrine insufficient (PEI) as it aids digestion.
Research suggests that PERT is well tolerated and helps with symptom management, weight stabilisations, toleration of oncology treatments and even survival. However, published literature indicates that prescribing rates are low globally among clinicians treating people with pancreatic cancer.
Paediatric series
Ketamine for cancer-related mucositis pain – series 42
In this series, we are seeking to establish the broad utility and toxicity of ketamine for children with chronic non-cancer pain and cancer pain in real-life situations.
Ketamine is widely used for paediatric general and regional anaesthesia, procedural sedation, as an adjunct to opioid analgesia, and as a low-dose continuous infusion for the treatment of both acute and complex pain.
If you can help us to collect data to improve the available evidence about the effectiveness of ketamine for children with cancer-related mucositis pain, please get in touch.
To express interest in participating in these series or to learn more about other series in the IMPACCT Rapid Program, visit uts.edu.au/rapid or email [email protected]
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 8 hours ago
Did you know COGNO members can join COSA at a discounted rate? Thank you to @cogno_trials for continuing Affiliated organisation membership with COSA. bit.ly/3s5mOC6
Read More >
COSAoncology 11 hours ago
Thank you @MASC_Trials for continuing your Affiliated organisation membership with COSA. Don’t forget, MASC Trials members can join COSA at a discounted rate. bit.ly/3s5mOC6
Read More >
COSAoncology yesterday
Congratulations COSA members and friends who were recognised with #KingsBirthdayHonours including oncology nurse and researcher, Catherine Johnson AM, and radiation oncologists and researchers, Prof Michael Poulsen AM and Prof Gerard Fogarty OAM. These honours are well deserved
Read More >
COSAoncology yesterday
Need a reminder of how to renew your COSA membership? These steps show how: bit.ly/3s5mOC6
Read More >
COSAoncology 5 days ago
Join COSA, the national multidisciplinary community for health care professionals working in cancer care. Interested? Here’s how to join: bit.ly/3hXsDLm
Read More >
COSAoncology 6 days ago
Did you know @UTS_CST members can join COSA at a discounted rate? Thank you for continuing your Affiliated organisation membership with COSA! bit.ly/3s5mOC6
Read More >
COSAoncology 6 days ago
Check your inbox for the June Nutrition Group eNews for member updates, journal articles, PD and more. If you're not subscribed, login to your COSA member account bit.ly/4cI0nc3 to update your preferences. COSA members can view the eNews online at bit.ly/4jxMgbq
Read More >
COSAoncology 7 days ago
Call nominations for the 2025 COSA Psycho-Oncology Awards recognising outstanding contributions to psycho-oncology from members of COSA and @POCOG1. Nominations close 30 June 2025 and the awards will be presented at COSA-IPOS 2025 in Adelaide in November. bit.ly/4i9Avrg
Read More >
COSAoncology 8 days ago
Thank you to @ANZCHOG for continuing to be an Affiliated member organisation with COSA. We look forward to continuing our collaboration to improve cancer care. You can find a list of all COSA organisation members on our website: bit.ly/44ns3Oq
Read More >
COSAoncology 8 days ago
We are pleased that @ALLGtrials continue to be an Affiliated member organisation with COSA, and look forward to our ongoing collaboration to improve cancer care and control. ALLG members can join COSA at a discounted rate. Join or renew here: cosa.org.au/membership/mem…
Read More >